Prognostic Factors Associated With Disease Progression and Overall Survival in Patients With Myelodysplastic Syndromes Treated With Decitabine

Decitabine improves overall survival (OS) and reduces risk of progression to acute myeloid leukemia (AML) in myelodysplastic syndromes (MDS). In this retrospective analysis of data from 2 decitabine studies (n = 162), hemoglobin level > 10 g/dL, platelet count > 50 × 10(3)/μL, and lack of chro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jabbour, Elias, Garcia-Manero, Guillermo, Ravandi, Farhad, Faderl, Stefan, O'Brien, Susan, Fullmer, Amber, Cortes, Jorge E., Wierda, William, Kantarjian, Hagop
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4098775/
https://ncbi.nlm.nih.gov/pubmed/23260600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2012.11.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados